Literature DB >> 34126158

The surge in Covid related mucormycosis.

Somesh Chandra1, Rakesh Rawal2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34126158      PMCID: PMC8195687          DOI: 10.1016/j.jinf.2021.06.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   38.637


× No keyword cloud information.
Mucormycosis(MM), a sequelae of clinical event post COVID-19 infection, is an uncommon opportunistic infection caused by a filamentous fungus (class: Zygomycetes and order: Mucorales) with a high degree of morbidity & mortality. , The point to ponder therefore is, whether SARSCoV2 is the major culprit which compromises the immune system of the host and thereby make the host more vulnerable to this secondary opportunistic infection, thus accounting for higher incidence of MM during second wave in India? Earlier published literature including several retrospective case series analyses have reported vulnerability of immune-compromised patients with pre-existing comorbidities e.g. diabetic ketoacidosis(DKA) treated with systemic glucocorticoids, Zn supplement, and longer ICU stay with O2 support towards mucormycosis.3, 4, 5, 6, 7 However, These observations are not backed by sufficient scientific evidence to account for the proportionately higher Covid-associated MM in the second wave. There are several clinical forms of MM infection reported till date including pulmonary, gastrointestinal, cutaneous, and rhinocerebral. MM has a typical clinical presentation characterized by rapid progression of tissue necrosis due to sequential invasion and thrombosis of blood vessels. Rhino-cerebro-orbital mucormycosis, the major form in this pandemic is diagnosed through CT paranasal sinus and MRI brain. , It is now known that the surge in second wave is related, at least in part, to the new variants of concern in the SARSCOV-2 virus making it more transmissible and difficult to treat. , It was well established that the virus gains entry into cells using the ACE-2 receptors. A greater rate of endocytosis will be facilitated if the virus has additional “routes” of entry. Ibrahim et al. and others have reported that the GRP 78 could act as an alternative and additional route for the virus to gain entry into the host cell. , The genome of the prevalent SARSCoV2 variant (B.1.1.7 & B.6.117) in India is believed to be the cause of the increased infection. , In-silico studies have shown stable interaction between RBD domain of spike protein (C480-488,) with that of GRP 78 predicting its role in endocytosis. , It is to be noted that MM also have the same port of entry i.e GRP78 into the nasal and paranasal sinus mucosa through its coat protein CotH3. Two hypotheses can be formulated for over expression of GRP78 one due to High glucose and iron content found during DKA and second dexamethasone induced GRP78 expression and thus may facilitate the invasion of MM into target cells for further proliferation.21, 22, 23 There is still a less explored reason for GRP78 over expression namely endoplasmic reticulum(ER) stress. In perfectly healthy condition, the protein folding ability of endoplasmic reticulum matches with the body's protein synthesis ability. However, in stress condition e.g. virus infection cells accumulates excessively high number of unfolded viral structural proteins in ER leading to over expression of GRP78 at cell surface making the cells vulnerable to fungal pathogens e.g. MM.24, 25 The GRP 78 binding being common to both the new variants as well as MM, could explain both the higher transmissibility of SARSCoV2 and surge in COVID-19 associated MM in the second wave. We propose, therefore, that this is the right time to conduct a stringent medical audit of MM cases with a detailed questionnaire and medical records to identify risk predictors for future plans of action. Assessment of GRP78 expression in target cells or in circulation during hospital discharge, If not in all cases, at least in high-risk individuals like diabetics supplemented with steroid and had a history of long ICU admission, can be recommended. Additionally, such individuals could be considered for low-dose anti-fungal prophylaxis to decrease the morbidity and mortality due to MM.

CRediT authorship contribution statement

Somesh Chandra: Writing – original draft. Rakesh Rawal: Writing – original draft.

Declaration of Competing Interest

None.
  23 in total

1.  Mucormycosis in immunochallenged patients.

Authors:  Jane Pak; Veronica T Tucci; Albert L Vincent; Ramon L Sandin; John N Greene
Journal:  J Emerg Trauma Shock       Date:  2008-07

Review 2.  Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.

Authors:  Wentao Ni; Xiuwen Yang; Deqing Yang; Jing Bao; Ran Li; Yongjiu Xiao; Chang Hou; Haibin Wang; Jie Liu; Donghong Yang; Yu Xu; Zhaolong Cao; Zhancheng Gao
Journal:  Crit Care       Date:  2020-07-13       Impact factor: 9.097

3.  High GRP78 levels in Covid-19 infection: A case-control study.

Authors:  Ramazan Sabirli; Aylin Koseler; Tarik Goren; Ibrahim Turkcuer; Ozgur Kurt
Journal:  Life Sci       Date:  2020-11-19       Impact factor: 5.037

4.  Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico.

Authors:  Abdo A Elfiky; Ibrahim M Ibrahim
Journal:  J Infect       Date:  2021-01-22       Impact factor: 6.072

5.  Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU.

Authors:  Arnaud Fekkar; Alexandre Lampros; Julien Mayaux; Corentin Poignon; Sophie Demeret; Jean-Michel Constantin; Anne-Geneviève Marcelin; Antoine Monsel; Charles-Edouard Luyt; Marion Blaize
Journal:  Am J Respir Crit Care Med       Date:  2021-02-01       Impact factor: 21.405

6.  Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.

Authors:  Deepak Garg; Valliappan Muthu; Inderpaul Singh Sehgal; Raja Ramachandran; Harsimran Kaur; Ashish Bhalla; Goverdhan D Puri; Arunaloke Chakrabarti; Ritesh Agarwal
Journal:  Mycopathologia       Date:  2021-02-05       Impact factor: 2.574

7.  COVID-19 triggering mucormycosis in a susceptible patient: a new phenomenon in the developing world?

Authors:  Shweta Mallikarjun Revannavar; Supriya P S; Laxminarayana Samaga; Vineeth V K
Journal:  BMJ Case Rep       Date:  2021-04-27

8.  Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective.

Authors:  Ibrahim M Ibrahim; Abdo A Elfiky; Alaa M Elgohary
Journal:  Biochem Biophys Res Commun       Date:  2021-05-21       Impact factor: 3.575

Review 9.  GRP78 targeting: Hitting two birds with a stone.

Authors:  Abdo A Elfiky; Ahmed M Baghdady; Shehab A Ali; Marwan I Ahmed
Journal:  Life Sci       Date:  2020-08-22       Impact factor: 5.037

View more
  7 in total

1.  COVID-19 and black fungus: Analysis of the public perceptions through machine learning.

Authors:  Nafiz Imtiaz Khan; Tahasin Mahmud; Muhammad Nazrul Islam
Journal:  Eng Rep       Date:  2021-11-14

2.  Image challenge: A diabetic man with facial swelling following recent Covid-19 infection.

Authors:  Melissa Chowdhury; Junko Takata; Issa Beegun; Chris Burd; Taranjit Tatla; Tumena Corrah
Journal:  Clin Infect Pract       Date:  2021-12-08

3.  When Worlds Collide: An Interesting Case of Rhinocerebral Mucormycosis Exacerbated by COVID-19 and Diabetic Ketoacidosis Complicated by Intraorbital Hematoma.

Authors:  Andrew J Ortega; Sara Alhariri; M Ammar Kalas; Jeff Taclob; Angelica Padilla; Abhizith Deoker
Journal:  Cureus       Date:  2022-01-13

4.  Pathogenetic factors fanning the flames of COVID-19 to cause rhino-orbito-cerebral mucormycosis: An observational study.

Authors:  Y Muralidhar Reddy; Sreekanth Yeduguri; Vishnu Swaroop Reddy N; Subhendu Parida; Shanti Naidu Kamatham; Lalitha Pidaparthi; Shyam K Jaiswal; Bhavana Sadhvani; Vijaya Tourani; Sudhir Kumar; Sundaram Challa; Jagarlapudi Mk Murthy
Journal:  J Mycol Med       Date:  2022-02-01       Impact factor: 3.746

Review 5.  COVID-19 and Plethora of Fungal Infections.

Authors:  Reetu Kundu; Nidhi Singla
Journal:  Curr Fungal Infect Rep       Date:  2022-04-09

6.  Utility of MGG and Papanicolaou stained smears in the detection of Mucormycosis in nasal swab/scraping/biopsy samples of COVID 19 patients.

Authors:  Ashish C Philip; Prarthna Madan; Sonal Sharma; Shukla Das
Journal:  Diagn Cytopathol       Date:  2021-12-29       Impact factor: 1.390

7.  COVID-19-Associated mucormycosis: Case series from a tertiary care hospital in South India.

Authors:  Shafeedha Rashbi K; T M Feroz Ali; Deepthi P N; Saranya C K; Rajan Joseph Payyappilly
Journal:  Access Microbiol       Date:  2022-06-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.